The results of the present study suggest that the subset of TER pathway genes (including the RGC genes) and multiple DEGs associated with alterations of this pathway might simultaneously be controlled by MYC in the PT and AT cells of HCC patients (Fig. 5A–E). The gene discussed is MYC; the disease is hepatocellular carcinoma.